Welcome to our Corporate client solution
Here you can administrate your corporate solutions users.
Your IP is registered with the company mentioned above and provides access to Life Science Focus.
Swedish–Danish Pila Pharma has received approval from the European Medicines Agency (EMA) to begin a clinical trial of the company’s drug candidate for obesity.